Cargando…

Clinical significance of systemic immune-inflammation index (SII) and C-reactive protein-to-albumin ratio (CAR) in patients with esophageal cancer: a meta-analysis

Background: Numerous studies have reported that systemic immune-inflammation index (SII) and C-reactive protein-to-albumin ratio (CAR) correlate with tumor progression and prognosis in various types of human cancer. The aim of this study is to systematically investigate the clinical significance of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yi, Xiao, Guoliang, Wang, Rong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6515544/ https://www.ncbi.nlm.nih.gov/pubmed/31190988 http://dx.doi.org/10.2147/CMAR.S190006

Ejemplares similares

Prognostic Significance of the Systemic Immune-Inflammation Index (SII) in Patients With Small Cell Lung Cancer: A Meta-Analysis
por: Zhou, Yuting, et al.
Publicado: (2022)

Prognostic and clinicopathological significance of C-reactive protein/albumin ratio (CAR) in patients with gastric cancer: A meta-analysis
por: Yu, Junhua, et al.
Publicado: (2021)

The role of systemic immune-inflammation index (SII) in the differential diagnosis of granulomatous and reactive LAP diagnosed by endobronchial ultrasonography
por: Kerget, Buğra, et al.
Publicado: (2023)

Exercise reduces systemic immune inflammation index (SII) in childhood cancer patients
por: Winker, Matteo, et al.
Publicado: (2021)

Retraction: Prognostic and clinicopathological significance of C-reactive protein/albumin ratio (CAR) in patients with gastric cancer: A meta-analysis
Publicado: (2022)

Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected esophageal squamous cell carcinoma
por: Gao, Yibo, et al.
Publicado: (2019)

Systemic immune-inflammation index, SII, for prognosis of elderly patients with newly diagnosed tumors
por: Li, Chan, et al.
Publicado: (2018)

Systemic Immune-Inflammation Index (SII) Predicts Increased Severity in Psoriasis and Psoriatic Arthritis
por: YORULMAZ, AHU, et al.
Publicado: (2020)

Association of systemic immune-inflammation index (SII) with presence of isolated coronary artery ectasia
por: Tosu, Aydın Rodi, et al.
Publicado: (2021)

Systemic Immune-Inflammation Index (SII) Correlates with Disease Severity in Hidradenitis Suppurativa Patients
por: Hayran, Yıldız, et al.
Publicado: (2023)

Prognostic impact of elevated pre-treatment systemic immune-inflammation index (SII) in hepatocellular carcinoma: A meta-analysis
por: Wang, Bolin, et al.
Publicado: (2020)

Association of the systemic immune-inflammation index (SII) and clinical outcomes in patients with stroke: A systematic review and meta-analysis
por: Huang, Yong-Wei, et al.
Publicado: (2022)

Postoperative Systemic Immune-Inflammation Index (SII): A Superior Prognostic Factor of Endometrial Cancer
por: Huang, Yihong, et al.
Publicado: (2021)

Association between systemic immune-inflammation index (SII) and survival outcome in patients with primary glioblastoma
por: Yang, Chao, et al.
Publicado: (2023)

The Systemic Immune-Inflammation Index (SII) Increases the Prognostic Significance of Lymphovascular Invasion in Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy
por: Jan, Hau-Chern, et al.
Publicado: (2022)

Neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and systemic immune inflammation index (SII) to predict postoperative pneumonia in elderly hip fracture patients
por: Yao, Wei, et al.
Publicado: (2023)

Prognostic significance of the ratio of fibrinogen and albumin in human malignancies: a meta-analysis
por: Zhang, Yi, et al.
Publicado: (2019)

Systemic Immune-Inflammation Index (SII) Predicts Poor Survival in Pancreatic Cancer Patients Undergoing Resection
por: Jomrich, Gerd, et al.
Publicado: (2019)

The systemic immune-inflammation index (SII) is an independent prognostic parameter of survival in patients with invasive vulvar cancer
por: Bartl, Thomas, et al.
Publicado: (2020)

The clinical value of neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII), platelet-to-lymphocyte ratio (PLR) and systemic inflammation response index (SIRI) for predicting the occurrence and severity of pneumonia in patients with intracerebral hemorrhage
por: Wang, Rui-Hong, et al.
Publicado: (2023)

Prognostic Value of Systemic Immune-Inflammation Index (SII) in Patients with Glioblastoma: A Comprehensive Study Based on Meta-Analysis and Retrospective Single-Center Analysis
por: Yang, Chao, et al.
Publicado: (2022)

Evaluation of Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Systemic Immune–Inflammation Index (SII) as Potential Biomarkers in Patients with Sporadic Medullary Thyroid Cancer (MTC)
por: Modica, Roberta, et al.
Publicado: (2023)

The significance of C-reactive protein to albumin ratio in patients with decompensated cirrhosis
por: Oikonomou, Theodora, et al.
Publicado: (2020)

Predictive value of systemic immune inflammation index (SII) and prognostic nutritional index (PNI) on mortality after below-knee amputation
por: Yilmaz, Selçuk, et al.
Publicado: (2023)

Systemic immune-inflammation index (SII) is a useful prognostic indicator for patients with squamous cell carcinoma of the esophagus
por: Feng, Ji-Feng, et al.
Publicado: (2017)

A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio
por: Wei, Xiao-li, et al.
Publicado: (2015)

Clinical Significance of C-Reactive Protein to Albumin Ratio in Patients with Hepatocellular Carcinoma: A Meta-Analysis
por: Lin, Nanping, et al.
Publicado: (2020)

Prognostic role of pre-treatment C-reactive protein/albumin ratio in esophageal cancer: a meta-analysis
por: Liu, Zhenhua, et al.
Publicado: (2019)

Prognostic value of the C-reactive protein/Albumin Ratio (CAR) in patients with operable soft tissue sarcoma
por: Liang, Yao, et al.
Publicado: (2017)

Exploring the Correlation Between the Systemic Immune Inflammation Index (SII), Systemic Inflammatory Response Index (SIRI), and Type 2 Diabetic Retinopathy
por: Wang, Shuqi, et al.
Publicado: (2023)

Systemic immune-inflammation index (SII): A More Promising Inflammation-Based Prognostic Marker for Patients with synchronic colorectal peritoneal carcinomatosis
por: Yan, Qian, et al.
Publicado: (2020)

Systemic Immune-Inflammation Index (SII) Can Be an Early Indicator for Predicting the Severity of Acute Pancreatitis: A Retrospective Study
por: Liu, Xingming, et al.
Publicado: (2021)

The Significance of Preoperative Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Systemic Inflammatory Index (SII) in Predicting Severity and Adverse Outcomes in Acute Calculous Cholecystitis
por: Serban, Dragos, et al.
Publicado: (2023)

Predictive Value of the Platelet Times Neutrophil-to-Lymphocyte Ratio (SII Index) for COVID-19 In-Hospital Mortality
por: Ballaz, Santiago J., et al.
Publicado: (2023)

High Neutrophil-To-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammation Index (SII) Are Markers of Longer Survival After Metastasectomy of Patients With Liver-Only Metastasis of Rectal Cancer
por: Polk, Nándor, et al.
Publicado: (2022)

A novel inflammation-based prognostic index for patients with esophageal squamous cell carcinoma: neutrophil lymphocyte ratio/albumin ratio
por: Zhao, Qiang, et al.
Publicado: (2017)

Prognostic Value of the C-Reactive Protein/Albumin Ratio and Systemic Immune-Inflammation Index for Patients With Colorectal Liver Metastasis Undergoing Curative Resection
por: Deng, Yuxiang, et al.
Publicado: (2021)

Value of the Systemic Immune-Inflammatory Index (SII) in Predicting the Prognosis of Patients With Peripartum Cardiomyopathy
por: Zhang, Yuan, et al.
Publicado: (2022)

Prognostic and Clinicopathological Significance of C-Reactive Protein to Albumin Ratio in Patients With Pancreatic Cancer: A Meta-Analysis
por: Xie, Qinfen, et al.
Publicado: (2020)

C-Reactive Protein/Albumin Ratio (CAR) as a Prognostic Factor in Patients with Non-Metastatic Nasopharyngeal Carcinoma
por: He, ShaSha, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ilckcceo77vmv52e5g0diqli4h